Stay updated on Safety Tolerability in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability in IPF Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:28:00.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the study details related to a randomized, placebo-controlled, double-blind study evaluating the efficacy, safety, and tolerability of MN-001 in subjects with Idiopathic Pulmonary Fibrosis (IPF).
    Difference
    0.1%
    Check dated 2024-06-06T14:18:57.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age range, health conditions, and prior treatments required for inclusion. Previously, this section had no information provided.
    Difference
    40%
    Check dated 2024-05-22T20:32:53.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The value 'Go to the classic website Go to the classic website 5 2' on the webpage has been updated to 'Site Map 6 0', indicating a change related to the type of intervention, possibly concerning medical and healthcare-related publications and documentation.
    Difference
    1%
    Check dated 2024-05-01T17:38:49.000Z thumbnail image

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.